Impulsive Behavior Clinical Trial
Official title:
A Randomized, Double-Blind Study of Neural Circuit Responses to COMT Inhibitors
In this study, we seek to understand the effects of tolcapone, an FDA-approved COMT inhibitor, on reward choice and response inhibition, two measures we have previously shown to be altered in subjects with alcoholism. We now plan to test the hypothesis that COMT regulation of cortical dopamine levels is critical for regulation financial choices. Specifically, we propose that the lower levels of cortical dopamine present in individuals with the val158val COMT genotype reduces the inhibitory effect of frontal cortical areas on impulsive choice; an idea that extends previous hypotheses about the negative consequences of decreased prefrontal dopamine levels on inhibitory control. Moreover, this hypothesis suggests that inhibiting COMT may slow the degradation of dopamine and thereby decrease impulsivity.
Drug consumption despite adverse consequences is a defining feature of human addiction (DSM-IV-TR, 2004). Impulsivity, a tendency to choose an immediate action despite delayed adverse consequences, is a major risk factor for tobacco, psychostimulant, opioid and alcohol abuse. In humans, impulsivity can be quantified by presenting subjects with a choice between a small immediate monetary reward or a larger but delayed reward. We recently found that the val158val allele for the enzyme catechol-O-methyltransferase (COMT), which is associated with more rapid cortical dopamine catabolism and thus lower cortical dopamine levels correlates with greater impulsivity and greater fMRI blood oxygen level dependent (BOLD) signal in dorsolateral prefrontal and posterior parietal cortices. The first phase of the study will involve healthy controls. The second phase of the study will involve abstinent alcoholics matched for age, education, and gender. Subjects will range in age between 18 and 50 years old. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03898336 -
Eat2beNICE Vitamins and Nutrients as Supplementation for Impulsivity, Irritability, and Compulsivity
|
N/A | |
Completed |
NCT03484377 -
Cortical Dynamics of Inhibitory Control: A Concurrent tDCS-MEG Study
|
N/A | |
Terminated |
NCT03527550 -
Cognitive Control Training for Urgency in a Naturalistic Clinical Setting
|
N/A | |
Recruiting |
NCT05894980 -
How to Reduce Suicidal Thoughts and Impulsivity in Depression
|
N/A | |
Recruiting |
NCT03218670 -
Your Health in On Click
|
N/A | |
Not yet recruiting |
NCT04811807 -
Clinical Response of Impulsivity After Brain Stimulation in Parkinson's Disease
|
||
Completed |
NCT02740582 -
Effects of Tolcapone on Decision Making and Alcohol Intake in Alcohol Users
|
Phase 2 | |
Not yet recruiting |
NCT02595164 -
Common Decision Making Deficits in Suicidal Behaviors and Eating Disorders
|
N/A | |
Recruiting |
NCT04960969 -
The Effects of Time-Restricted Eating Model
|
N/A | |
Not yet recruiting |
NCT06226467 -
Neurobehavioral Affective Control Training
|
N/A | |
Not yet recruiting |
NCT03498937 -
Effects of tDCS on Impulsiveness Among People Suffering From Borderline Personality Disorder
|
N/A | |
Completed |
NCT03200873 -
Effects of rTMS on Impulsivity and Empathy
|
N/A | |
Terminated |
NCT03838484 -
Effects of Transdermal Nicotine on Response Inhibition to Emotional Cues in Schizophrenia
|
N/A | |
Completed |
NCT04290533 -
HD-tDCS Over the dACC in High Trait Impulsivity
|
N/A | |
Completed |
NCT05031559 -
Episodic Future Thinking and Compassion
|
N/A | |
Recruiting |
NCT05875181 -
Examining the Impact of Transcranial Focused Ultrasound (tFUS) on Reward Neural Circuitry
|
N/A | |
Not yet recruiting |
NCT03190681 -
Motivation and Methylphenidate
|
Early Phase 1 | |
Completed |
NCT01805401 -
tDCS Applied to the OFC: Effects on Decision-Making and Impulse Control
|
N/A | |
Completed |
NCT03006653 -
Understanding Daily Fluctuations in Self-Regulation
|
N/A | |
Active, not recruiting |
NCT04785677 -
Researching Resiliency in Stressful Experiences (RISE) Program for Men Leaving Incarceration
|
N/A |